Revenue and EBITDA grew strongly above inflation in H1 2024, driven by domestic patient growth and operational efficiency, while net debt/EBITDA improved to 0.5x. Expansion continued with five new hospitals and increased bed capacity by 10%.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.